Evidence map›Paper›PMID 31880198›Full record

ArticleAutophagy2020

The protease activity of human ATG4B is regulated by reversible oxidative modification.

Xueping Zheng, Zuolong Yang, Qianqian Gu, Fan Xia, Yuanyuan Fu, Peiqing Liu, Xiao-Ming Yin, Min Li

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Enhanced Levels of Peroxisome-Derived HAntioxidants (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xueping ZhengSchool of Pharmaceutical Sciences, Sun Yat-Sen University, National-Local Joint Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Engineering Laboratory of Druggability and New Drug Evaluation, Provincial Key Laboratory of New Drug Design and Evaluation , Guangzhou, Guangdong, China.
Zuolong YangSchool of Pharmaceutical Sciences, Sun Yat-Sen University, National-Local Joint Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Engineering Laboratory of Druggability and New Drug Evaluation, Provincial Key Laboratory of New Drug Design and Evaluation , Guangzhou, Guangdong, China.
Qianqian GuSchool of Pharmaceutical Sciences, Sun Yat-Sen University, National-Local Joint Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Engineering Laboratory of Druggability and New Drug Evaluation, Provincial Key Laboratory of New Drug Design and Evaluation , Guangzhou, Guangdong, China.
Fan XiaSchool of Pharmaceutical Sciences, Sun Yat-Sen University, National-Local Joint Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Engineering Laboratory of Druggability and New Drug Evaluation, Provincial Key Laboratory of New Drug Design and Evaluation , Guangzhou, Guangdong, China.
Yuanyuan FuSchool of Pharmaceutical Sciences, Sun Yat-Sen University, National-Local Joint Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Engineering Laboratory of Druggability and New Drug Evaluation, Provincial Key Laboratory of New Drug Design and Evaluation , Guangzhou, Guangdong, China.
Peiqing LiuSchool of Pharmaceutical Sciences, Sun Yat-Sen University, National-Local Joint Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Engineering Laboratory of Druggability and New Drug Evaluation, Provincial Key Laboratory of New Drug Design and Evaluation , Guangzhou, Guangdong, China.
Xiao-Ming YinDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine , Indianapolis, IN, USA.
Min LiSchool of Pharmaceutical Sciences, Sun Yat-Sen University, National-Local Joint Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Engineering Laboratory of Druggability and New Drug Evaluation, Provincial Key Laboratory of New Drug Design and Evaluation , Guangzhou, Guangdong, China.ORCID 0000-0002-5657-8675
Indiana University School of Medicine

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macroautophagy/autophagy plays a pivotal role in cytoplasmic material recycling and metabolic turnover, in which ATG4B functions as a "scissor" for processing pro-LC3 and lipidated LC3 to drive the autophagy progress. Mounting evidence has demonstrated the tight connection between ROS and autophagy during various pathological situations. Coincidentally, several studies have shown that ATG4B is potentially regulated by redox modification, but the underlying molecular mechanism and its relationship with autophagy is ambiguous. In this study, we verified that ATG4B activity was definitely regulated in a reversible redox manner. We also determined that Cys292 and Cys361 are essential sites of ATG4B to form reversible intramolecular disulfide bonds that respond to oxidative stress. Interestingly, we unraveled a new phenomenon that ATG4B concurrently formed disulfide-linked oligomers at Cys292 and Cys361, and that both sites underwent redox modifications thereby modulating ATG4B activity. Finally, increased autophagic flux and decreased oxidation sensitivity were observed in Cys292 and Cys361 double site-mutated cells under normal growth conditions. In conclusion, our research reveals a novel molecular mechanism that oxidative modification at Cys292 and Cys361 sites regulates ATG4B function, which modulates autophagy.

Indexed as

Gene Expression Regulation, EnzymologicAutophagyAutophagy-Related ProteinsCysteineCysteine EndopeptidasesDisulfidesHEK293 CellsHeLa CellsHumansHydrogen PeroxideMicrotubule-Associated ProteinsMutationOxidation-ReductionOxidative StressOxygenReactive Oxygen SpeciesATG4B protein, humanAutophagy-Related ProteinsCysteineCysteine EndopeptidasesDisulfidesHydrogen PeroxideMAP1LC3A protein, humanMicrotubule-Associated ProteinsOxygenReactive Oxygen SpeciesATG4Bautophagydisulfide bondoligomeroxidative modificationredox

Identifiers

PMID31880198
PMCPMC8386634
OpenAlexW2997999213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.